Table 3. The predictive value of FUT3 and the combined hazard models in ccRCC patients.
Overall survival | Recurrence free survival | |||||
---|---|---|---|---|---|---|
Models | C-index | AIC | p value | C-index | AIC | p value |
FUT3 | 0.606 | 773.041 | 0.608 | 847.870 | ||
TNM stage | 0.726 | 731.536 | 0.088 | 0.683 | 826.163 | 0.019 |
TNM stage + FUT3 | 0.751 | 727.496 | 0.725 | 819.997 | ||
UISS | 0.770 | 701.346 | 0.111 | 0.762 | 777.415 | 0.004 |
UISS + FUT3 | 0.789 | 699.420 | 0.785 | 774.583 | ||
SSIGN | 0.778 | 679.953 | 0.042 | 0.761 | 760.206 | 0.009 |
SSIGN + FUT3 | 0.807 | 675.563 | 0.798 | 754.550 | ||
Leibovich | 0.829 | 654.813 | 0.009 | 0.818 | 731.214 | 0.002 |
Leibovich + FUT3 | 0.854 | 652.612 | 0.849 | 727.700 |
Abbreviations: ccRCC = clear cell renal cell carcinoma; FUT3 = Fucosyltransferase 3; UISS = University of California Los Angeles Integrated Staging System; SSIGN = Stage Size, Grade and Necrosis; p value = p valuefor AIC.